Merck, Cidara Therapeutics granted early termination by US FTC
MLex Summary: Merck and Cidara Therapeutics, Inc. were granted early termination by the US Federal Trade Commission on Dec. 19, according to a securities filing. Merck announced its proposed acquisition of...To view the full article, register now.
Already a subscriber? Click here to view full article